Pathways to Success: Improving Diabetes Outcomes in Primary Care Practice

1.5 Credits - CME/CPE | Expires 05/15/2015

This activity is supported by an educational grant from Amylin Pharmaceuticals, Inc.

Dates of Certification/Accreditation: May 14, 2014 - May 14, 2015

Estimated time to complete activity: 1.5 hours

Fee: Free of charge

Faculty

Stephen Brunton, MD

Executive Vice PresidentPrimary Care Education ConsortiumAdjunct Clinical ProfessorUniversity of North CarolinaCharlotte, North Carolina

Disclosure

Consultant: Abbott Laboratories, AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, Janssen Pharmaceuticals, Lilly, Novo Nordisk, Novartis, Sanofi-Aventis, Teva

Speaker’s Bureau: Boehringer-Ingelheim, Janssen Pharmaceuticals, Lilly, Novo Nordisk, Teva

Davida Kruger, MSN, BC-ADM, BC-APN

Henry Ford Health SystemDivision of Endocrinology, Diabetes, and Bone DiseasesDetroit, Michigan

Disclosure

Grant/Research Support: Bristol-Myers Squibb, Eli Lilly

Consultant: Dexcom, Inc., Johnson & Johnson, Novo Nordisk

Speaker’s Bureau: Bristol-Myers Squibb, Johnson & Johnson

Eden Miller, DO

Family PhysicianHigh Lakes Health CareCEO, Diabetes NationTMBend, Oregon

Disclosure

Speaker’s Bureau: Abbott Laboratories, Eli Lilly, GlaxoSmithKline, Janssen Pharmaceuticals, Novo Nordisk

Albert Tzeel, MD, MHSA, FACPE

Regional Medical Director for Senior ProductsHumana Inc. North FloridaJacksonville, Florida

Disclosure

Employment/stock ownership: Humana Inc.

Intended Audience

Medical directors, pharmacy directors, specialty pharmacists, and other managed care professionals who oversee the care of patients with T2DM in various clinical settings.

Educational Objectives

Upon completion of this knowledge-based educational activity, the participants should be able to:

  • Explore the impact of type 2 diabetes mellitus (T2DM) including factors contributing to suboptimal control of glucose and other clinical metrics
  • Review current clinical practice guidelines and algorithms focusing on management of treatment-experienced patients with poorly controlled DM
  • Examine safety and efficacy of currently used treatments forT2DM
  • Explore treatment strategies, including various combination regimens
  • Evaluate the impact of disease management programs on clinical measures, healthcare expenditures and inpatient utilization

Accreditation/Designation of Credit Statements

®

®

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Physicians’ Education Resource, LLC and the Pharmacy Times Office of Continuing Professional Education. Physicians’ Education Resource, LLC is accredited by the ACCME to provide continuing medical education for physicians.

®

Physicians’ Education Resource, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (.15 CEUs) under the ACPE universal activity number 0290-9999-14-044-H01-P. The activity is available for CE credit through May 15, 2015.

Disclosure, Conflict of Interest Identification, and Resolution Policy

®

®

In accordance with ACCME and ACPE guidelines, all persons who are in a position to control content of CME/CE activities are required to disclose any relevant financial relationships with commercial interests. If a conflict is identified, it is the responsibility of Physicians’ Education Resource LLC (PER) and Pharmacy Times Office of Continuing Professional Education to initiate a mechanism to resolve it. COI was resolved for this activity using a multi-step process, including external peer review.

The following staff and planners have no relevant financial relationships with commercial interests to disclose:

®

PER and Pharmacy Times Office of Continuing Professional Education

David Heckard; Maryjo Dixon, RPh; Donna Fausak; Dru S. Dace, PhD

®

PER and Pharmacy Times Office of Continuing Professional Education use an anonymous peer review process to resolve conflicts of interest. The peer reviewer for this CME/CE activity has no relevant financial relationships with commercial interests to disclose.

Obtaining Credit (Pharmacists): To receive CPE credit, pharmacist participants must log onto www.pharmacytimes.org where you will be directed to the activity pre-test. Pharmacists must complete the pre-test, watch the video in its entirety, complete the post-test with a passing score of 70% or higher, evaluate this activity and complete the online request for credit form. These steps must be completed in order to receive credit. Please ensure your account is updated with your NABP e-profile ID and date of birth (MMDD format). Credit cannot be uploaded into CPE Monitor if you do not have your NABP e-profile or date of birth entered into your profile on www.pharmacytimes.org.

TM

Obtaining Credit (Physicians): To receive AMA PRA Category 1 Credit, physicians must complete the online pre-test, view the video in its entirety, complete the online post-test with a passing score of 70% or higher, and complete the online activity evaluation and request for credit form. After successful completion of these steps, physicians may immediately download a CME certificate.

Off-Label Disclosure and Disclaimer

The contents of this CME/CE activity may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Physicians and pharmacists should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.

For additional information about approved uses, including approved indications, contraindications, and warnings, participants are advised to consult prescribing information for all products discussed. The information provided in this CME/CE activity is for continuing medical and pharmacy education purposes only and is not meant to substitute for the independent medical or pharmacy judgment of a physician or pharmacist relative to diagnostic, treatment, or management options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of Physicians’ Education Resource®, LLC, Pharmacy Times Office of Continuing Professional Education, or the company that provided commercial support for this CME/CE activity.

Begin This CME/CPE Activity

For Physicians (CME Credit) — Click Here to Proceed to Activity

For Pharmacists (CPE Credit) — Click Here to Proceed to Activity

Provider Contact Information

For questions about this CME/CE activity, physicians can contact:

Physicians' Education Resource®, LLC

666 Plainsboro Rd. Suite 356

Plainsboro, NJ 08536

Phone (609) 378-3701

info@gotoper.com

666 Plainsboro Rd. Suite 356

Plainsboro, NJ 08536

Pharmacists can contact:

Pharmacy Times Office of Continuing Professional Education

666 Plainsboro Road | Suite 356

Plainsboro, NJ 08536

ceinfo@pharmacytimes.com

System Requirements

PC-based participants

Required: Windows® 7, Vista, XP, 2003 Server or 2000

Macintosh®-based participants

Required Mac OS® X 10.4.11 (Tiger®) or newer

Privacy Policy and Terms of Use Information: www.pharmacytimes.com/terms_condition.